UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000050334
Receipt number R000057153
Scientific Title Change characteristics of the high frequency variability index (HFVI) in patients receiving ultrasound-guided peripheral nerve block
Date of disclosure of the study information 2023/02/28
Last modified on 2024/04/23 09:49:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Change characteristics of the high frequency variability index (HFVI) in patients receiving ultrasound-guided peripheral nerve block

Acronym

Change characteristics of the high frequency variability index (HFVI) in patients receiving ultrasound-guided peripheral nerve block

Scientific Title

Change characteristics of the high frequency variability index (HFVI) in patients receiving ultrasound-guided peripheral nerve block

Scientific Title:Acronym

Changes of the high frequency variability index (HFVI) in ultrasound-guided peripheral nerve block

Region

Japan


Condition

Condition

patients recieving the upper limb surgery

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

to evaluate whether the High Frequency Variability Index(HFVI) can be used as an indicator of efficacy of the ultrasound-guided brachial plexus blocks (USBPB) by revealing the effect of effective USBPB on HFVI

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

the changes of HFVI after USBPB

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

patients undergoing the orthopaedic upper limb surgery

Key exclusion criteria

the patients with serious cardiovascular dosease, who are American Society of Anestheologists physical status class 3 or more, who are administered an anticholinergic agent,with arrhythmia or implanted pacemaker and inappropriate recordind of HFVI.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name MOTOI
Middle name
Last name KUMAGAI

Organization

Iwate medical university hospital

Division name

Department of Anesthesiology

Zip code

028-3695

Address

2-1-1, Idaidori, Yahaba-cho, Shiwa-gun, Iwate, Japan

TEL

019-613-7111

Email

motoij@iwate-med.ac.jp


Public contact

Name of contact person

1st name MOTOI
Middle name
Last name KUMAGAI

Organization

Iwate medical university hospital

Division name

Department of Anesthesiology

Zip code

028-3695

Address

2-1-1, Idaidori, Yahaba-cho, Shiwa-gun, Iwate, Japan

TEL

019-613-7111

Homepage URL


Email

motoij@iwate-med.ac.jp


Sponsor or person

Institute

Iwate medical university hospital

Institute

Department

Personal name



Funding Source

Organization

Iwate medical university hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Iwate medical university hospital

Address

2-1-1, Idaidori, Yahaba-cho, Shiwa-gun, Iwate, Japan

Tel

019-613-7111

Email

motoij@iwate-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 02 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2023 Year 02 Month 02 Day

Date of IRB

2023 Year 03 Month 08 Day

Anticipated trial start date

2023 Year 02 Month 22 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

observational study


Management information

Registered date

2023 Year 02 Month 14 Day

Last modified on

2024 Year 04 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057153